GenomeNet

Database: UniProt
Entry: Q7Z494
LinkDB: Q7Z494
Original site: Q7Z494 
ID   NPHP3_HUMAN             Reviewed;        1330 AA.
AC   Q7Z494; Q5JPE3; Q5JPE6; Q68D99; Q6NVH3; Q7Z492; Q7Z493; Q8N9R2; Q8NCM5;
AC   Q96N70; Q96NK2;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2003, sequence version 1.
DT   27-MAR-2024, entry version 174.
DE   RecName: Full=Nephrocystin-3;
GN   Name=NPHP3; Synonyms=KIAA2000;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), NUCLEOTIDE SEQUENCE [MRNA] OF
RP   117-1330, NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), NUCLEOTIDE SEQUENCE
RP   [MRNA] OF 584-1330 (ISOFORM 3), INTERACTION WITH NPHP1, TISSUE SPECIFICITY,
RP   AND VARIANTS NPHP3 THR-360; SER-386; HIS-397; PRO-1141; VAL-1221; ARG-1252
RP   AND THR-1314.
RX   PubMed=12872122; DOI=10.1038/ng1216;
RA   Olbrich H., Fliegauf M., Hoefele J., Kispert A., Otto E., Volz A.,
RA   Wolf M.T., Sasmaz G., Trauer U., Reinhardt R., Sudbrak R., Antignac C.,
RA   Gretz N., Walz G., Schermer B., Benzing T., Hildebrandt F., Omran H.;
RT   "Mutations in a novel gene, NPHP3, cause adolescent nephronophthisis,
RT   tapeto-retinal degeneration and hepatic fibrosis.";
RL   Nat. Genet. 34:455-459(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=12056414; DOI=10.1093/dnares/9.2.47;
RA   Ohara O., Nagase T., Mitsui G., Kohga H., Kikuno R., Hiraoka S.,
RA   Takahashi Y., Kitajima S., Saga Y., Koseki H.;
RT   "Characterization of size-fractionated cDNA libraries generated by the in
RT   vitro recombination-assisted method.";
RL   DNA Res. 9:47-57(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 319-1330.
RC   TISSUE=Brain, Mammary gland, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 555-1330 (ISOFORM 6).
RC   TISSUE=Fetal kidney, and Lymph node;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 7).
RC   TISSUE=Salivary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=20462968; DOI=10.1152/ajprenal.00043.2010;
RA   Zhou W., Dai J., Attanasio M., Hildebrandt F.;
RT   "Nephrocystin-3 is required for ciliary function in zebrafish embryos.";
RL   Am. J. Physiol. 299:F55-F62(2010).
RN   [7]
RP   MYRISTOYLATION AT GLY-2, INTERACTION WITH UNC119 AND UNC119B, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=22085962; DOI=10.1101/gad.173443.111;
RA   Wright K.J., Baye L.M., Olivier-Mason A., Mukhopadhyay S., Sang L.,
RA   Kwong M., Wang W., Pretorius P.R., Sheffield V.C., Sengupta P.,
RA   Slusarski D.C., Jackson P.K.;
RT   "An ARL3-UNC119-RP2 GTPase cycle targets myristoylated NPHP3 to the primary
RT   cilium.";
RL   Genes Dev. 25:2347-2360(2011).
RN   [8]
RP   INTERACTION WITH CEP164.
RX   PubMed=22863007; DOI=10.1016/j.cell.2012.06.028;
RA   Chaki M., Airik R., Ghosh A.K., Giles R.H., Chen R., Slaats G.G., Wang H.,
RA   Hurd T.W., Zhou W., Cluckey A., Gee H.Y., Ramaswami G., Hong C.J.,
RA   Hamilton B.A., Cervenka I., Ganji R.S., Bryja V., Arts H.H.,
RA   van Reeuwijk J., Oud M.M., Letteboer S.J., Roepman R., Husson H.,
RA   Ibraghimov-Beskrovnaya O., Yasunaga T., Walz G., Eley L., Sayer J.A.,
RA   Schermer B., Liebau M.C., Benzing T., Le Corre S., Drummond I., Janssen S.,
RA   Allen S.J., Natarajan S., O'Toole J.F., Attanasio M., Saunier S.,
RA   Antignac C., Koenekoop R.K., Ren H., Lopez I., Nayir A., Stoetzel C.,
RA   Dollfus H., Massoudi R., Gleeson J.G., Andreoli S.P., Doherty D.G.,
RA   Lindstrad A., Golzio C., Katsanis N., Pape L., Abboud E.B., Al-Rajhi A.A.,
RA   Lewis R.A., Omran H., Lee E.Y., Wang S., Sekiguchi J.M., Saunders R.,
RA   Johnson C.A., Garner E., Vanselow K., Andersen J.S., Shlomai J.,
RA   Nurnberg G., Nurnberg P., Levy S., Smogorzewska A., Otto E.A.,
RA   Hildebrandt F.;
RT   "Exome capture reveals ZNF423 and CEP164 mutations, linking renal
RT   ciliopathies to DNA damage response signaling.";
RL   Cell 150:533-548(2012).
RN   [9]
RP   INTERACTION WITH NEK8.
RX   PubMed=23418306; DOI=10.1093/hmg/ddt070;
RA   Frank V., Habbig S., Bartram M.P., Eisenberger T., Veenstra-Knol H.E.,
RA   Decker C., Boorsma R.A., Goebel H., Nuernberg G., Griessmann A., Franke M.,
RA   Borgal L., Kohli P., Voelker L.A., Doetsch J., Nuernberg P., Benzing T.,
RA   Bolz H.J., Johnson C., Gerkes E.H., Schermer B., Bergmann C.;
RT   "Mutations in NEK8 link multiple organ dysplasia with altered Hippo
RT   signalling and increased c-MYC expression.";
RL   Hum. Mol. Genet. 22:2177-2185(2013).
RN   [10]
RP   INTERACTION WITH ANKS6; INVS AND NEK8.
RX   PubMed=23793029; DOI=10.1038/ng.2681;
RA   Hoff S., Halbritter J., Epting D., Frank V., Nguyen T.M., van Reeuwijk J.,
RA   Boehlke C., Schell C., Yasunaga T., Helmstadter M., Mergen M., Filhol E.,
RA   Boldt K., Horn N., Ueffing M., Otto E.A., Eisenberger T., Elting M.W.,
RA   van Wijk J.A., Bockenhauer D., Sebire N.J., Rittig S., Vyberg M., Ring T.,
RA   Pohl M., Pape L., Neuhaus T.J., Elshakhs N.A., Koon S.J., Harris P.C.,
RA   Grahammer F., Huber T.B., Kuehn E.W., Kramer-Zucker A., Bolz H.J.,
RA   Roepman R., Saunier S., Walz G., Hildebrandt F., Bergmann C.,
RA   Lienkamp S.S.;
RT   "ANKS6 is a central component of a nephronophthisis module linking NEK8 to
RT   INVS and NPHP3.";
RL   Nat. Genet. 45:951-956(2013).
RN   [11]
RP   VARIANT RHPD1 GLN-973, INVOLVEMENT IN MKS7, FUNCTION, AND INTERACTION WITH
RP   INVS.
RX   PubMed=18371931; DOI=10.1016/j.ajhg.2008.02.017;
RA   Bergmann C., Fliegauf M., Bruechle N.O., Frank V., Olbrich H.,
RA   Kirschner J., Schermer B., Schmedding I., Kispert A., Kraenzlin B.,
RA   Nuernberg G., Becker C., Grimm T., Girschick G., Lynch S.A., Kelehan P.,
RA   Senderek J., Neuhaus T.J., Stallmach T., Zentgraf H., Nuernberg P.,
RA   Gretz N., Lo C., Lienkamp S., Schaefer T., Walz G., Benzing T., Zerres K.,
RA   Omran H.;
RT   "Loss of nephrocystin-3 function can cause embryonic lethality, Meckel-
RT   Gruber-like syndrome, situs inversus, and renal-hepatic-pancreatic
RT   dysplasia.";
RL   Am. J. Hum. Genet. 82:959-970(2008).
CC   -!- FUNCTION: Required for normal ciliary development and function.
CC       Inhibits disheveled-1-induced canonical Wnt-signaling activity and may
CC       also play a role in the control of non-canonical Wnt signaling which
CC       regulates planar cell polarity. Probably acts as a molecular switch
CC       between different Wnt signaling pathways. Required for proper
CC       convergent extension cell movements. {ECO:0000269|PubMed:18371931}.
CC   -!- SUBUNIT: Interacts with NPHP1 and INVS/NPHP2. Interacts (when
CC       myristoylated) with UNC119 and UNC119B; interaction is required for
CC       localization to cilium. Interacts with CEP164. Component of a complex
CC       containing at least ANKS6, INVS, NEK8 and NPHP3. ANKS6 may organize
CC       complex assembly by linking INVS and NPHP3 to NEK8 and INVS may target
CC       the complex to the proximal ciliary axoneme.
CC       {ECO:0000269|PubMed:12872122, ECO:0000269|PubMed:18371931,
CC       ECO:0000269|PubMed:22085962, ECO:0000269|PubMed:22863007,
CC       ECO:0000269|PubMed:23418306, ECO:0000269|PubMed:23793029}.
CC   -!- INTERACTION:
CC       Q7Z494; Q9UPV0: CEP164; NbExp=2; IntAct=EBI-2804263, EBI-3937015;
CC       Q7Z494; Q9Y265: RUVBL1; NbExp=2; IntAct=EBI-2804263, EBI-353675;
CC       Q7Z494; Q13432: UNC119; NbExp=3; IntAct=EBI-2804263, EBI-711260;
CC   -!- SUBCELLULAR LOCATION: Cell projection, cilium
CC       {ECO:0000269|PubMed:20462968, ECO:0000269|PubMed:22085962}.
CC       Note=Localization to cilium is mediated via interaction with UNC119 and
CC       UNC119B, which bind to the myristoyl moiety of the N-terminus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q7Z494-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7Z494-2; Sequence=VSP_014480, VSP_014481;
CC       Name=3;
CC         IsoId=Q7Z494-3; Sequence=VSP_014488, VSP_014489;
CC       Name=4;
CC         IsoId=Q7Z494-4; Sequence=VSP_014482, VSP_014483;
CC       Name=5;
CC         IsoId=Q7Z494-5; Sequence=VSP_014486, VSP_014487;
CC       Name=6;
CC         IsoId=Q7Z494-6; Sequence=VSP_014490, VSP_014491;
CC       Name=7;
CC         IsoId=Q7Z494-7; Sequence=VSP_014484, VSP_014485;
CC   -!- TISSUE SPECIFICITY: Widely expressed at low level. Expressed in heart,
CC       placenta, liver, skeletal muscle, kidney and pancreas. Expressed at
CC       very low level in brain and lung. {ECO:0000269|PubMed:12872122}.
CC   -!- DISEASE: Nephronophthisis 3 (NPHP3) [MIM:604387]: An autosomal
CC       recessive disorder resulting in end-stage renal disease. It is
CC       characterized by polyuria, polydipsia, anemia. Onset of terminal renal
CC       failure occurr significantly later (median age, 19 years) than in
CC       juvenile nephronophthisis. Renal pathology is characterized by
CC       alterations of tubular basement membranes, tubular atrophy and
CC       dilation, sclerosing tubulointerstitial nephropathy, and renal cyst
CC       development predominantly at the corticomedullary junction.
CC       {ECO:0000269|PubMed:12872122}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Renal-hepatic-pancreatic dysplasia 1 (RHPD1) [MIM:208540]: A
CC       disease characterized by cystic malformations of the kidneys, liver,
CC       and pancreas. The pathological findings consist of multicystic
CC       dysplastic kidneys, dilated and dysgenetic bile ducts, a dysplastic
CC       pancreas with dilated ducts, cysts, fibrosis and inflammatory
CC       infiltrates. {ECO:0000269|PubMed:18371931}. Note=The disease is caused
CC       by variants affecting the gene represented in this entry.
CC   -!- DISEASE: Meckel syndrome 7 (MKS7) [MIM:267010]: A disorder
CC       characterized by a combination of renal cysts and variably associated
CC       features including developmental anomalies of the central nervous
CC       system (typically encephalocele), hepatic ductal dysplasia and cysts,
CC       and polydactyly. {ECO:0000269|PubMed:18371931}. Note=The disease is
CC       caused by variants affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB70891.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC02709.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC04268.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY257864; AAP83423.1; -; mRNA.
DR   EMBL; AY257865; AAP83424.1; -; mRNA.
DR   EMBL; AY257866; AAP83425.1; -; mRNA.
DR   EMBL; AB082531; BAC02709.1; ALT_INIT; mRNA.
DR   EMBL; AK055253; BAB70891.1; ALT_INIT; mRNA.
DR   EMBL; AK055893; BAB71038.1; -; mRNA.
DR   EMBL; AK094015; BAC04268.1; ALT_INIT; mRNA.
DR   EMBL; AL832863; CAI46200.2; -; mRNA.
DR   EMBL; AL832877; CAI46202.1; -; Transcribed_RNA.
DR   EMBL; CR749498; CAH18321.1; -; mRNA.
DR   EMBL; BC068082; AAH68082.1; -; mRNA.
DR   CCDS; CCDS3078.1; -. [Q7Z494-1]
DR   RefSeq; NP_694972.3; NM_153240.4. [Q7Z494-1]
DR   PDB; 5L7K; X-ray; 2.10 A; B=2-7.
DR   PDBsum; 5L7K; -.
DR   AlphaFoldDB; Q7Z494; -.
DR   SMR; Q7Z494; -.
DR   BioGRID; 117962; 37.
DR   CORUM; Q7Z494; -.
DR   IntAct; Q7Z494; 26.
DR   MINT; Q7Z494; -.
DR   STRING; 9606.ENSP00000338766; -.
DR   CarbonylDB; Q7Z494; -.
DR   iPTMnet; Q7Z494; -.
DR   PhosphoSitePlus; Q7Z494; -.
DR   BioMuta; NPHP3; -.
DR   DMDM; 68565783; -.
DR   EPD; Q7Z494; -.
DR   jPOST; Q7Z494; -.
DR   MassIVE; Q7Z494; -.
DR   MaxQB; Q7Z494; -.
DR   PaxDb; 9606-ENSP00000338766; -.
DR   PeptideAtlas; Q7Z494; -.
DR   ProteomicsDB; 69163; -. [Q7Z494-1]
DR   ProteomicsDB; 69164; -. [Q7Z494-2]
DR   ProteomicsDB; 69165; -. [Q7Z494-3]
DR   ProteomicsDB; 69166; -. [Q7Z494-4]
DR   ProteomicsDB; 69167; -. [Q7Z494-5]
DR   ProteomicsDB; 69168; -. [Q7Z494-6]
DR   ProteomicsDB; 69169; -. [Q7Z494-7]
DR   Pumba; Q7Z494; -.
DR   Antibodypedia; 2070; 130 antibodies from 23 providers.
DR   DNASU; 27031; -.
DR   Ensembl; ENST00000337331.10; ENSP00000338766.5; ENSG00000113971.21. [Q7Z494-1]
DR   Ensembl; ENST00000383282.3; ENSP00000372769.2; ENSG00000113971.21. [Q7Z494-7]
DR   Ensembl; ENST00000683570.1; ENSP00000508409.1; ENSG00000113971.21. [Q7Z494-4]
DR   GeneID; 27031; -.
DR   KEGG; hsa:27031; -.
DR   MANE-Select; ENST00000337331.10; ENSP00000338766.5; NM_153240.5; NP_694972.3.
DR   UCSC; uc003epe.3; human. [Q7Z494-1]
DR   AGR; HGNC:7907; -.
DR   CTD; 27031; -.
DR   DisGeNET; 27031; -.
DR   GeneCards; NPHP3; -.
DR   GeneReviews; NPHP3; -.
DR   HGNC; HGNC:7907; NPHP3.
DR   HPA; ENSG00000113971; Low tissue specificity.
DR   MalaCards; NPHP3; -.
DR   MIM; 208540; phenotype.
DR   MIM; 267010; phenotype.
DR   MIM; 604387; phenotype.
DR   MIM; 608002; gene.
DR   neXtProt; NX_Q7Z494; -.
DR   OpenTargets; ENSG00000113971; -.
DR   OpenTargets; ENSG00000274810; -.
DR   Orphanet; 93591; Infantile nephronophthisis.
DR   Orphanet; 93589; Late-onset nephronophthisis.
DR   Orphanet; 3032; NPHP3-related Meckel-like syndrome.
DR   Orphanet; 294415; Renal-hepatic-pancreatic dysplasia.
DR   Orphanet; 3156; Senior-Loken syndrome.
DR   PharmGKB; PA31708; -.
DR   VEuPathDB; HostDB:ENSG00000113971; -.
DR   eggNOG; KOG1840; Eukaryota.
DR   GeneTree; ENSGT00940000156398; -.
DR   HOGENOM; CLU_1744706_0_0_1; -.
DR   InParanoid; Q7Z494; -.
DR   OMA; TWHEENP; -.
DR   OrthoDB; 38814at2759; -.
DR   PhylomeDB; Q7Z494; -.
DR   TreeFam; TF314010; -.
DR   PathwayCommons; Q7Z494; -.
DR   Reactome; R-HSA-5624138; Trafficking of myristoylated proteins to the cilium.
DR   SignaLink; Q7Z494; -.
DR   BioGRID-ORCS; 27031; 36 hits in 1151 CRISPR screens.
DR   GeneWiki; NPHP3; -.
DR   GenomeRNAi; 27031; -.
DR   Pharos; Q7Z494; Tbio.
DR   PRO; PR:Q7Z494; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q7Z494; Protein.
DR   Bgee; ENSG00000113971; Expressed in superficial temporal artery and 190 other cell types or tissues.
DR   ExpressionAtlas; Q7Z494; baseline and differential.
DR   Genevisible; Q7Z494; HS.
DR   GO; GO:0097546; C:ciliary base; IBA:GO_Central.
DR   GO; GO:0097543; C:ciliary inversin compartment; IBA:GO_Central.
DR   GO; GO:0005929; C:cilium; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; IEA:GOC.
DR   GO; GO:0003283; P:atrial septum development; IMP:BHF-UCL.
DR   GO; GO:0060271; P:cilium assembly; ISS:UniProtKB.
DR   GO; GO:0060026; P:convergent extension; IBA:GO_Central.
DR   GO; GO:0060027; P:convergent extension involved in gastrulation; IGI:BHF-UCL.
DR   GO; GO:0071908; P:determination of intestine left/right asymmetry; IMP:BHF-UCL.
DR   GO; GO:0007368; P:determination of left/right symmetry; IMP:BHF-UCL.
DR   GO; GO:0071910; P:determination of liver left/right asymmetry; IMP:BHF-UCL.
DR   GO; GO:0035469; P:determination of pancreatic left/right asymmetry; IMP:BHF-UCL.
DR   GO; GO:0071909; P:determination of stomach left/right asymmetry; IMP:BHF-UCL.
DR   GO; GO:0060287; P:epithelial cilium movement involved in determination of left/right asymmetry; IC:BHF-UCL.
DR   GO; GO:0007163; P:establishment or maintenance of cell polarity; IEA:Ensembl.
DR   GO; GO:0030198; P:extracellular matrix organization; IEA:Ensembl.
DR   GO; GO:0001947; P:heart looping; IMP:BHF-UCL.
DR   GO; GO:0001822; P:kidney development; IMP:BHF-UCL.
DR   GO; GO:0060993; P:kidney morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0006629; P:lipid metabolic process; IEA:Ensembl.
DR   GO; GO:0030324; P:lung development; IMP:BHF-UCL.
DR   GO; GO:0048496; P:maintenance of animal organ identity; IMP:HGNC-UCL.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:UniProtKB.
DR   GO; GO:1905515; P:non-motile cilium assembly; IEA:Ensembl.
DR   GO; GO:0045494; P:photoreceptor cell maintenance; IMP:HGNC-UCL.
DR   GO; GO:2000095; P:regulation of Wnt signaling pathway, planar cell polarity pathway; IDA:BHF-UCL.
DR   GO; GO:0072189; P:ureter development; IMP:BHF-UCL.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   Gene3D; 1.25.40.10; Tetratricopeptide repeat domain; 3.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   InterPro; IPR019734; TPR_repeat.
DR   PANTHER; PTHR45641:SF1; NEPHROCYSTIN-3; 1.
DR   PANTHER; PTHR45641; TETRATRICOPEPTIDE REPEAT PROTEIN (AFU_ORTHOLOGUE AFUA_6G03870); 1.
DR   Pfam; PF13424; TPR_12; 3.
DR   Pfam; PF13176; TPR_7; 1.
DR   SMART; SM00028; TPR; 8.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   SUPFAM; SSF48452; TPR-like; 2.
DR   PROSITE; PS50005; TPR; 8.
DR   PROSITE; PS50293; TPR_REGION; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell projection; Ciliopathy; Cilium;
KW   Coiled coil; Disease variant; Lipoprotein; Meckel syndrome; Myristate;
KW   Nephronophthisis; Reference proteome; Repeat; TPR repeat;
KW   Wnt signaling pathway.
FT   INIT_MET        1
FT                   /note="Removed"
FT   CHAIN           2..1330
FT                   /note="Nephrocystin-3"
FT                   /id="PRO_0000106301"
FT   REPEAT          471..504
FT                   /note="TPR 1"
FT   REPEAT          885..918
FT                   /note="TPR 2"
FT   REPEAT          920..942
FT                   /note="TPR 3"
FT   REPEAT          943..976
FT                   /note="TPR 4"
FT   REPEAT          985..1018
FT                   /note="TPR 5"
FT   REPEAT          1027..1060
FT                   /note="TPR 6"
FT   REPEAT          1093..1126
FT                   /note="TPR 7"
FT   REPEAT          1135..1168
FT                   /note="TPR 8"
FT   REPEAT          1177..1210
FT                   /note="TPR 9"
FT   REPEAT          1219..1252
FT                   /note="TPR 10"
FT   REPEAT          1261..1294
FT                   /note="TPR 11"
FT   REGION          1296..1330
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          83..207
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        1301..1330
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000269|PubMed:22085962"
FT   VAR_SEQ         1..720
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12056414"
FT                   /id="VSP_014480"
FT   VAR_SEQ         132..181
FT                   /note="ALQKTYQKILREKESALEAKYQAMERAATFEHDRDKVKRQFKIFRETKEN
FT                   -> VTPGWAATPGDPWEARPSCSLSKPSGFESSAETAHFNLRGHILFESEMIP (in
FT                   isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_014482"
FT   VAR_SEQ         132..150
FT                   /note="ALQKTYQKILREKESALEA -> GLAAVARSRLTATWNSWAQ (in
FT                   isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_014484"
FT   VAR_SEQ         151..1330
FT                   /note="Missing (in isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_014485"
FT   VAR_SEQ         182..1330
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_014483"
FT   VAR_SEQ         224..239
FT                   /note="AAGTQCEYWTGGALGS -> VSLESDQHPGIFIANF (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:12872122"
FT                   /id="VSP_014486"
FT   VAR_SEQ         240..1330
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:12872122"
FT                   /id="VSP_014487"
FT   VAR_SEQ         630..636
FT                   /note="QVEKHMK -> VVAYTSS (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12872122,
FT                   ECO:0000303|PubMed:17974005"
FT                   /id="VSP_014488"
FT   VAR_SEQ         637..1330
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12872122,
FT                   ECO:0000303|PubMed:17974005"
FT                   /id="VSP_014489"
FT   VAR_SEQ         697..704
FT                   /note="EKKLERHC -> CWESRQFR (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_014490"
FT   VAR_SEQ         705..1330
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_014491"
FT   VAR_SEQ         1330
FT                   /note="R -> RKVQSNLLSPEGLSNICAQEKTTRFTSS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12056414"
FT                   /id="VSP_014481"
FT   VARIANT         360
FT                   /note="S -> T (in NPHP3; dbSNP:rs119456960)"
FT                   /evidence="ECO:0000269|PubMed:12872122"
FT                   /id="VAR_022815"
FT   VARIANT         386
FT                   /note="N -> S (in NPHP3; dbSNP:rs142021049)"
FT                   /evidence="ECO:0000269|PubMed:12872122"
FT                   /id="VAR_022816"
FT   VARIANT         397
FT                   /note="R -> H (in NPHP3; dbSNP:rs755094682)"
FT                   /evidence="ECO:0000269|PubMed:12872122"
FT                   /id="VAR_022817"
FT   VARIANT         973
FT                   /note="R -> Q (in RHPD1; dbSNP:rs119456963)"
FT                   /evidence="ECO:0000269|PubMed:18371931"
FT                   /id="VAR_044121"
FT   VARIANT         1141
FT                   /note="L -> P (in NPHP3; dbSNP:rs1057521090)"
FT                   /evidence="ECO:0000269|PubMed:12872122"
FT                   /id="VAR_022818"
FT   VARIANT         1221
FT                   /note="A -> V (in NPHP3; dbSNP:rs202048210)"
FT                   /evidence="ECO:0000269|PubMed:12872122"
FT                   /id="VAR_022819"
FT   VARIANT         1252
FT                   /note="S -> R (in NPHP3; dbSNP:rs143451766)"
FT                   /evidence="ECO:0000269|PubMed:12872122"
FT                   /id="VAR_022820"
FT   VARIANT         1305
FT                   /note="R -> C (in dbSNP:rs35485382)"
FT                   /id="VAR_044122"
FT   VARIANT         1314
FT                   /note="S -> T (in NPHP3; likely benign; dbSNP:rs75316802)"
FT                   /evidence="ECO:0000269|PubMed:12872122"
FT                   /id="VAR_022821"
FT   CONFLICT        223
FT                   /note="T -> TT (in Ref. 4; CAI46202)"
FT                   /evidence="ECO:0000305"
FT   HELIX           3..6
FT                   /evidence="ECO:0007829|PDB:5L7K"
SQ   SEQUENCE   1330 AA;  150864 MW;  99C1F17C9A5117F8 CRC64;
     MGTASSLVSP AGGEVIEDTY GAGGGEACEI PVEVKPKARL LRNSFRRGAG AAAGAGPGSL
     PRGVGAGGLL GASFKSTGSS VPELEYAAAE YERLRKEYEI FRVSKNQELL SMGRREAKLD
     TENKRLRAEL QALQKTYQKI LREKESALEA KYQAMERAAT FEHDRDKVKR QFKIFRETKE
     NEIQDLLRAK RELESKLQRL QAQGIQVFDP GESDSDDNCT DVTAAGTQCE YWTGGALGSE
     PSIGSMIQLQ QSFRGPEFAH SSIDVEGPFA NVNRDDWDIA VASLLQVTPL FSHSLWSNTV
     RCYLIYTDET QPEMDLFLKD YSPKLKRMCE TMGYFFHAVY FPIDVENQYL TVRKWEIEKS
     SLVILFIHLT LPSLLLEDCE EAFLKNPEGK PRLIFHRLED GKVSSDSVQQ LIDQVSNLNK
     TSKAKIIDHS GDPAEGVYKT YICVEKIIKQ DILGFENTDL ETKDLGSEDS IPEEDDFGDV
     LWDIHDEQEQ METFQQASNS AHELGFEKYY QRLNDLVAAP APIPPLLVSG GPGSGKSLLL
     SKWIQLQQKN SPNTLILSHF VGRPMSTSSE SSLIIKRLTL KLMQHSWSVS ALTLDPAKLL
     EEFPRWLEKL SARHQGSIII VIDSIDQVQQ VEKHMKWLID PLPVNVRVIV SVNVETCPPA
     WRLWPTLHLD PLSPKDAKSI IIAECHSVDI KLSKEQEKKL ERHCRSATTC NALYVTLFGK
     MIARAGRAGN LDKILHQCFQ CQDTLSLYRL VLHSIRESMA NDVDKELMKQ ILCLVNVSHN
     GVSESELMEL YPEMSWTFLT SLIHSLYKMC LLTYGCGLLR FQHLQAWETV RLEYLEGPTV
     TSSYRQKLIN YFTLQLSQDR VTWRSADELP WLFQQQGSKQ KLHDCLLNLF VSQNLYKRGH
     FAELLSYWQF VGKDKSAMAT EYFDSLKQYE KNCEGEDNMS CLADLYETLG RFLKDLGLLS
     QAIVPLQRSL EIRETALDPD HPRVAQSLHQ LASVYVQWKK FGNAEQLYKQ ALEISENAYG
     ADHPYTAREL EALATLYQKQ NKYEQAEHFR KKSFKIHQKA IKKKGNLYGF ALLRRRALQL
     EELTLGKDTP DNARTLNELG VLYYLQNNLE TADQFLKRSL EMRERVLGPD HPDCAQSLNN
     LAALCNEKKQ YDKAEELYER ALDIRRRALA PDHPSLAYTV KHLAILYKKM GKLDKAVPLY
     ELAVEIRQKS FGPKHPSVAT ALVNLAVLYS QMKKHVEALP LYERALKIYE DSLGRMHPRV
     GETLKNLAVL SYEGGDFEKA AELYKRAMEI KEAETSLLGG KAPSRHSSSG DTFSLKTAHS
     PNVFLQQGQR
//
DBGET integrated database retrieval system